ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Nice breakout on ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) on decent volume. Buyable on a pullback to the pivot.

Chipotle Mexican Grill, Inc. (CMG): Buy on the Dip

Recent headlines concerning an E. coli outbreak combined with a lighter-than-expected earnings report to careen Chipotle (CMG) shares from $740 to $600, a decline of nearly 20%. While the stock’s longer-term fundamentals have some questions, the short-term charts favor a rally as they have breached dramatically oversold conditions.
Last week, CMG shares touched $600 for the first time since July, triggering a psychological support level. Our models rank the stock as a short-term bullish candidate with a short-term price target of $675 as the overreaction to recent events has opened the doors to bullish traders.

Stratasys, Ltd. (NASDAQ: SSYS)

Stratasys Ltd. provides additive manufacturing (AM) solutions for the creation of parts used in the processes of designing and manufacturing products; and for the direct manufacture of end parts. Its AM systems utilize its patented fused deposition modeling and inkjet-based PolyJet technologies to enable the production of prototypes, tools used for production and manufactured goods directly from three-dimensional (3D) CAD files or other 3D content.
Take a look at the 1-year chart of Stratasys (NASDAQ: SSYS) with the added notations:

SSYS has been in a solid downtrend for the past year. However, the stock has been trading sideways on top of a $25 support (green) during the most recent three months. Now that the stock appears to be testing that support level again, traders should be able to expect some sort of bounce. However, if the $25 support were to break, lower prices should follow.

The Tale of the Tape: SSYS has a key level of support at $25. A trader could enter a long position at $25 with a stop placed under the level. If the stock were to break below the support a short position could be entered instead.

Oil could hit US$130 as U.S. output "falls off a cliff," says analyst

Emad Mostaque has had a profound change of heart on oil prices. The analyst with London-based consultancy Ecstrat says US$130 per barrel crude could be less than a year away for the European benchmark as lower prices drive demand in both emerging and developed markets, while a weakening stream of capex dollars constrains new exploration and production.
“What we are seeing is supply is about to roll over dramatically. Demand is continuing to rise,” he said an in interview with BNN. (more)